Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for Fatigue in ALS
NCT00614926Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jun 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of modafinil in amyotrophic lateral sclerosis (ALS), sponsored by New York State Psychiatric Institute. Started Jun 2006; status: completed.
02
Drugs
modafinil
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00614926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00614926.